FDAsafety guidance72% confidence
Guidance Documents for Rare Disease Drug Development
Source: FDA
Why This Matters
Why this matters: sets a safety guidance precedent in the same sub-indication (rare disease) as Merck Sharp & Dohme LLC.
Regulatory Analysis
Supporting Context
- Therapeutic area
- Genetics · Familial Mediterranean Fever
- Sub-indication
- Rare Disease
Related signal: Study on Genetics of Familial Mediterranean Fever and Related Disorders Launched